Free Trial
NASDAQ:NUTX

Nutex Health (NUTX) Stock Price, News & Analysis

Nutex Health logo
$79.59 -4.20 (-5.01%)
As of 03:26 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Nutex Health Stock (NASDAQ:NUTX)

Key Stats

Today's Range
$77.21
$83.70
50-Day Range
$83.79
$137.83
52-Week Range
$17.51
$184.27
Volume
151,914 shs
Average Volume
152,400 shs
Market Capitalization
$442.49 million
P/E Ratio
6.72
Dividend Yield
N/A
Price Target
$252.50
Consensus Rating
Buy

Company Overview

Nutex Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
62nd Percentile Overall Score

NUTX MarketRank™: 

Nutex Health scored higher than 62% of companies evaluated by MarketBeat, and ranked 486th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Nutex Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Nutex Health has only been the subject of 1 research reports in the past 90 days.

  • Read more about Nutex Health's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nutex Health is 6.64, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 269.28.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nutex Health is 6.64, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 82.73.

  • Price to Book Value per Share Ratio

    Nutex Health has a P/B Ratio of 2.13. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Nutex Health's valuation and earnings.
  • Percentage of Shares Shorted

    25.20% of the float of Nutex Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Nutex Health has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nutex Health has recently decreased by 1.44%, indicating that investor sentiment is improving.
  • Dividend Yield

    Nutex Health does not currently pay a dividend.

  • Dividend Growth

    Nutex Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    25.20% of the float of Nutex Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Nutex Health has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nutex Health has recently decreased by 1.44%, indicating that investor sentiment is improving.
  • News Sentiment

    Nutex Health has a news sentiment score of 0.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.13 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 21 news articles for Nutex Health this week, compared to 5 articles on an average week.
  • Search Interest

    7 people have searched for NUTX on MarketBeat in the last 30 days. This is an increase of 17% compared to the previous 30 days.
  • MarketBeat Follows

    7 people have added Nutex Health to their MarketBeat watchlist in the last 30 days. This is an increase of 600% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Nutex Health insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    36.92% of the stock of Nutex Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 5.32% of the stock of Nutex Health is held by institutions.

  • Read more about Nutex Health's insider trading history.
Receive NUTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nutex Health and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NUTX Stock News Headlines

The day and month stocks are most likely to crash next
Good News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history gives him 90% historical confidence that stocks will end 2025 up. However, he also has bad news: the same data also tells him the REAL market crash will likely arrive in 2026.tc pixel
See More Headlines

NUTX Stock Analysis - Frequently Asked Questions

Nutex Health's stock was trading at $31.69 on January 1st, 2025. Since then, NUTX stock has increased by 149.1% and is now trading at $78.94.

Nutex Health Inc. (NASDAQ:NUTX) announced its quarterly earnings results on Tuesday, May, 13th. The company reported $2.56 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $2.71. The business had revenue of $211.79 million for the quarter, compared to the consensus estimate of $81.09 million. Nutex Health had a trailing twelve-month return on equity of 42.08% and a net margin of 10.76%.
Read the conference call transcript
.

Nutex Health shares reverse split on Wednesday, July 3rd 2024.The 1-10 reverse split was announced on Wednesday, July 3rd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Top institutional investors of Nutex Health include Topline Capital Management LLC (5.56%), American Century Companies Inc. (1.87%), Marshall Wace LLP (1.70%) and Geode Capital Management LLC (1.42%). Insiders that own company stock include Thomas T Vo, Jon Christian Bates, Joshua Detillio, John J Waters, Pamela W Montgomery and Michael Lee Reed.
View institutional ownership trends
.

Shares of NUTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nutex Health investors own include Predictive Oncology (POAI), Ford Motor (F), Wells Fargo & Company (WFC), JPMorgan Chase & Co. (JPM), Abbott Laboratories (ABT), Bank of America (BAC) and Cricut (CRCT).

Company Calendar

Last Earnings
5/13/2025
Today
9/02/2025
Next Earnings (Estimated)
9/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Business Services
Current Symbol
NASDAQ:NUTX
CIK
1479681
Employees
1,150
Year Founded
N/A

Price Target and Rating

High Price Target
$300.00
Low Price Target
$205.00
Potential Upside/Downside
+201.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
$11.89
Trailing P/E Ratio
7.05
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$52.18 million
Net Margins
10.76%
Pretax Margin
27.66%
Return on Equity
42.08%
Return on Assets
11.80%

Debt

Debt-to-Equity Ratio
1.02
Current Ratio
2.27
Quick Ratio
2.26

Sales & Book Value

Annual Sales
$479.95 million
Price / Sales
0.97
Cash Flow
$13.17 per share
Price / Cash Flow
6.36
Book Value
$37.13 per share
Price / Book
2.26

Miscellaneous

Outstanding Shares
5,560,000
Free Float
3,504,000
Market Cap
$465.87 million
Optionable
Not Optionable
Beta
-0.17
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:NUTX) was last updated on 9/2/2025 by MarketBeat.com Staff
From Our Partners